Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Stephan Spahn

2PUBLICATIONS
10CO-AUTHORS
Molecular targetsRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Feb 12, 2024
The molecular interaction pattern of lenvatinib enables inhibition of wild-type or kinase-mutated FGFR2-driven cholangiocarcinoma.

Stephan Spahn, Fabian Kleinhenz, Ekaterina Shevchenko

|Mar 01, 2022
Comprehensive clinical and virological characterization of three cases of fulminant liver failure owing to HSV1 primary infection.

Stephan Spahn, Reimer Riessen, Christoph P Berg

Pageof 1

Frequent Collaborators

1 joint publications

Christoph P Berg

1 joint publications

Klaus Hamprecht

1 joint publications

Ekaterina Shevchenko

1 joint publications

Aaron Stahl

1 joint publications

Thales Kronenberger

1 joint publications

Stefan A Laufer

1 joint publications

Marius Horger

1 joint publications

Klaus Schulze-Osthoff

1 joint publications

Antti Poso

1 joint publications

Michael Bitzer

Frequent Collaborators

1 joint publications

Christoph P Berg

1 joint publications

Klaus Hamprecht

1 joint publications

Ekaterina Shevchenko

1 joint publications

Aaron Stahl

Top Related Videos

A Combined 3D Tissue Engineered <em>In Vitro</em>/<em>In Silico</em> Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered <em>In Vitro</em>/<em>In Silico</em> Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on : Apr 06, 2016

10.2K
<em>Ex Vivo</em> Infection of Murine Epidermis with Herpes Simplex Virus Type 1
11:56

<em>Ex Vivo</em> Infection of Murine Epidermis with Herpes Simplex Virus Type 1

Published on : Aug 24, 2015

11.3K
See more related videos

Top Related Videos

A Combined 3D Tissue Engineered <em>In Vitro</em>/<em>In Silico</em> Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered <em>In Vitro</em>/<em>In Silico</em> Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on : Apr 06, 2016

10.2K
<em>Ex Vivo</em> Infection of Murine Epidermis with Herpes Simplex Virus Type 1
11:56

<em>Ex Vivo</em> Infection of Murine Epidermis with Herpes Simplex Virus Type 1

Published on : Aug 24, 2015

11.3K
See more related videos